1,038 results found

Pharmaceutical disputes, being the largest and fastest-growing business sectors in the world are increasingly being settled through international arbitration, particularly in the context of ...

The Bombay High Court examines whether food safety authorities can maintain an indefinite licence suspension after documented compliance improvements, addressing the critical distinction between precautionary regulatory powers and punitive measures. The case explores how a hotel's compliance score jumped from 69% to 97% within weeks, yet remained suspended for months through two rounds of adjudication.

Drug Repurposing, the emerging trend resulting from increasing cost of new drug discovery, researches, trails and generic competition.

Various food products are imported in India from different countries.

With 2024 coming to a close and 2025 starting to take shape, the healthcare and pharmaceutical sectors appear set to build on the positive momentum accumulated in the last year.

In the past couple of months, the healthcare and pharmaceutical sectors have undergone significant regulatory and policy shifts, highlighting a sustained focus on transparency, quality assurance, and industry facilitation.

The draft amendment to the Drugs and Cosmetic Rules, 1945 was published by the Department of Health and Family Welfare under the Ministry of Health and Family Welfare on August 28, 2018, primarily setting out ...

The misrepresentation of trademarks in the pharmaceutical sector can have disastrous consequences and can prove to be fatal.

Trademark Infringement In India's pharmaceutical Companies is prospering, with tremendous expansion over the last few decades.

One of the most shocking news during the recent times for sports fans and legal fraternity, around the globe, has been Maria Sharapova's admittance towards using the banned endurance-enhancing drug known as ‘Meldonium'.

"It is easy to get a thousand prescriptions, but hard to get one single remedy" so goes a popular Chinese proverb which succinctly summaries the pharmacy market in India and the debate surrounding e-pharmacies.

In this Newsletter, we bring to you some interesting developments in the field of Indian Intellectual Property law that took place in the months of February and March 2024.

The regulation of prices of drugs in the NPPP-2012 would be on the basis of regulating the prices of formulations through 'Market Based Pricing'.

The outbreak of the COVID-19 pandemic has created a significant impact on the healthcare and pharmaceutical industries.

The Food Safety and Standards Authority of India ("FSSAI"), vide notification dated July 1, 2024, has enabled instant issuances of licenses/registrations under the Food Safety and Standards...

A discussion on the aim of the National Food Security Bill.

Biosimilar infringement disputes in India are still a comparatively new but growing field of pharmaceutical patent law. The Delhi High Court's Order dated 18 July 2025 in E.R. Squibb...